Introduction
Preterm parturition is a syndrome (Romero, Gomez et al., 1997; Romero R, Espinoza J et al., 2004) that is one of the leading causes for perinatal morbidity and mortality. Moreover, prematurity is a leading cause for neonatal mortality, as well as short and long term morbidity. The incidence of preterm delivery is constantly increasing, crossing the 12% in the USA, and it's annual cost reached 26.2 billion US dollars in 2005, posing a huge burden on public health (Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes, 2007). Prematurity can be either spontaneous due to preterm labor with intact membranes (PTL) or preterm prelabor rupture of the chorioamniotic membranes (preterm PROM); or indicated, meaning induced preterm delivery by the medical team due to maternal (i.e. preeclampsia) or fetal (growth restriction, non-reassuring fetal heart rate tracing) indication (Goldenberg, Culhane et al., 2008) . The incidence of the latter group, especially after 34 weeks of gestation, is constantly rising ( Outcomes, 1980) . This has been associated with the trend to delay childbearing, indeed, more than 50 percent of these women were 35 years of age or older. In recent years, an unintended consequence of the use of these technologies, multiple gestations and the increased risk for preterm delivery, has become a focus of attention, and the institute of Medicine in the USA has concluded that "Fertility treatments are a significant contributor to preterm birth among both multiple and singleton pregnancies." (Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes, 2007) . The mechanisms in which assisted reproduction technologies increases the risk for preterm birth are still under investigation. Aside the contribution of ART to the increase number of multiple gestations (especially twins) that increases the risk for preterm delivery; The mechanisms leading to preterm delivery in singleton gestations conceived through ART have not been thoroughly investigated. Preliminary evidence suggests that some of the underlying maternal conditions that lead to infertility (i.e. inflammation and insulin resistance) may contribute to this observation. The current chapter will explore the epidemiology, underlying mechanisms, and possible tools for the prevention of preterm delivery in pregnancies conceived by assisted reproduction.
Infertility: Treatments, epidemiology and trends

Definitions
The most commonly used definition of infertility is a failure to conceive after 12 months of regular, unprotected intercourse. However, existing definitions of infertility lack uniformity, rendering comparisons of prevalence between countries or over time problematic. The absence of an agreed definition also compromises clinical management and undermines the impact of research findings. Gurunath at al suggested that the definition will be based on the duration of trying for pregnancy coupled with female age. (Gurunath, Pandian et al., 2011) According to the report of The Centers for Disease Control and Prevention (CDC), in 2002, 7% of married couples in which the woman was of reproductive age (2.1 million couples) reported that they had not used contraception for 12 months and the woman had not become pregnant. Many of these patients are treated by ARTs. These technologies are defined by the CDC as procedures in which the ovum and the sperm are handled in the laboratory. During the past few decades several options of ART have developed including: 1) in vitro fertilization (IVF); 2) intra-cytoplasmic sperm injection (ICSI); 3) gamete intrafallopian transfer (GIFT) and 4) zygote intra-fallopian transfer (ZIFT) (Centers for Disease Control and Prevention 2008).
What is the magnitude of ART utilization in developed countries?
The use of infertility treatments has risen dramatically in the past 10 years and has been associated with the trend to delay childbearing. Today, over 1% of all infants born in the United States every year are conceived using ART; and the number of ART cycles performed has nearly doubled, from 87,636 cycles in 1999 to 148,055 in 2008 . Similarly, the number of live-birth in 2008 (46, 326) was more than twice the number recorded 1999 (21, 746) . Because in many of the ART pregnancies more than one infant is born alive (e.g., twins, triplets), the total number of infants born is greater than the number of live-birth. The trend in the number of infants delivered after ART cycles was in accord to the trends observed in the number of pregnancies and live-births. Thus, the number of infants born in 2008, (61, 426 ) was more than twice than the 30,629 that were delivered in 1999 (Figure 1 ). Outside the USA, The Canadian Assisted Reproductive Technologies Register (CARTR), in its 2007 annual publication, reported a 12% increase in the total number of ART cycles, and an increase in the rate of clinical pregnancies and live-birth, along with a decrease in highorder multiple births in comparison to these parameters in 2006 (Gunby, Bissonnette et al., 2011) . While in Europe, according to the 10th annual European Society of Human Reproduction and Embryology (ESHRE) publication the reported number of ART cycles has increased, with a marginal increase in pregnancy rates, even though fewer embryos were transferred and the multiple delivery rates have declined (1994) . This report includes 20 countries, where all clinics report their activity to the IVF register. Altogether, a total of 359,110 cycles were performed in a population of 422.5 million, corresponding to 850 cycles per million inhabitants. The IVF cycles rates of clinical pregnancy per ovum aspiration and per embryo transfer were 29.0 and 32.4%, respectively; while the corresponding ICSI cycles rates were 29.9 and 33.0%, respectively (1994) . In spite of the new guidelines, transferring of 2 embryos is still the most prevalent choice in the European Union. ART often is categorized according to whether the procedure used a woman's own eggs (self) or eggs from another woman (donor) and according to whether the embryos used were newly fertilized (fresh) or previously fertilized, frozen, and then thawed (frozen). For approximately 71% of ART cycles performed in USA in 2008, self-fresh eggs or embryos were used. ART cycles that used self-frozen embryos were the next most common type, accounting for approximately 17% of the total. In about 12% of cycles, eggs or embryos were donated by another woman (Figure 2 ). Delaying childbearing may be attributed to several reasons, beginning with the longer life span, greater accessibility to education and career opportunities for women, and the existence of effective means of birth control (Stein, 1985; Berkowitz, Skovron et al., 1990) . Men and women recognized the direct relationship between older maternal age and the declined in fertility (Tough, Benzies et al., 2006; Tough, Benzies et al., 2007) , however, there is a popular concept that IVF treatment can reverse the effects of age (Maheshwari, Porter et al., 2008) . Interestingly, along with acknowledgment in the success of ART there is a lack of awareness regarding the effect of maternal age over perinatal complications during pregnancy. Women are not aware of the increased risk of preeclampsia, stillbirth, caesarean delivery, multiple births and preterm delivery associated with delayed childbirth to elderly stages of life (Tough, Benzies et al., 2006; Tough, Benzies et al., 2007) . Postponement of motherhood beyond 35 years of age influences many aspects of reproduction from conceiving through embryonic implantation all the way until delivery. The effect of maternal age on her ability to conceive is well documented. Populations that do not use contraceptives and practice unprotected intercourse give the best estimation of the ability of normal women to conceive. Based on 10 different populations living between the 17th and the 20th Centuries that did not use contraceptives, Menken et al (Menken, Trussell et al., 1986) reported that the fertility rate remains relatively stable until a woman is in her late 30s and then decreases substantially from more than 400 pregnancies per 1000 women per year at the age of 30, to only 100 pregnancies per 1000 women per year by the age of 45. The decline in fertility as a function of women's age was also demonstrated in a donor insemination programmed in which the cause of infertility was related to male factors alone and the women were assumed to be normal. Pregnancy rates at 1 year declined from 74% among women below the age of 30 years to 61.5% among women aged 31-35 years and 55.8% among women aged 36-41 years (Schwartz and Mayaux, 1982) . After conceiving, the risk of spontaneous miscarriage increases as a function of maternal age. In a prospective population-based register linkage study, involving 12,221,546 pregnancies of 634,272 Danish women from 1978 to 1992, older maternal age was a significant risk factor for spontaneous pregnancy loss irrespective of the number of previous miscarriages and parity. The risk of a spontaneous abortion in women aged 20-24 years was 8.9% and it climbed up to 74.7% in those aged 45 years or older (Nybo Andersen, Wohlfahrt et al., 2000) . Ben Kroon et all performed a cytogenetic evaluation for the products of conception obtained from patients with first trimester abortion who had a dilatation and curettage (D&C). The rate of embryos with aneuploidy in women aged ≥35 years was significantly higher than that of those younger than 35 years (45.7%, vs. 34.8%, respectively; P=.018) (Kroon, Harrison et al., 2011) . The derived rates apply to women whose only risk factor is advanced maternal age. The categories analyzed were trisomy 21 (Down's syndrome), Trisomy 18 (Edwards' syndrome), trisomy 13 (Patau's syndrome), 47XXY (Klinefelter's syndrome), 47,XXX, and a group of other clinically significant abnormalities that were considered collectively. The rate of all these chromosomal abnormalities in this study was about five per 1,000 at age 35 years, 15 per 1,000 at age 40 years, and 50 per 1,000 at age 45 years (Hook, Cross et al., 1983) . Savva et al (Savva, Walker et al., 2010) reviewed the records of prenatal and postnatal diagnoses from seven UK regional congenital anomaly registers and two Australian registers from 1997 to 2004. These dataset included 4.5 million deliveries, of which 975 diagnosed as having trisomy 13 and 2254 had trisomy 18. In addition, the authors reported that since 1989 until 1996 there was an increase, by 13% in the 7 rate of trisomy 13 and by 25% in the rate of trisomy 18. These findings are consistent with those predicted to be associated with the increases in maternal age (Savva, Walker et al., 2010) . The link between Down syndrome and advanced maternal age deserves special attention. This association was already reported by Penrose in the mid 1930's (Penrose, 1933; Penrose, 1934) . Lately, Graves Allen et al (Allen, Freeman et al., 2009 ) examined the origin of the meiotic error leading to the association between maternal age and chromosome 21 nondisjunction. They emphasis that the a significant association between advanced maternal age and chromosome 21 non-disjunction was restricted to meiotic errors in the egg and was not observed in sperm or in post-zygotic mitotic errors. The authors reported that the advanced maternal age was significantly associated with a higher rate of non-disjunction in both meiosis I (MI) and meiosis II (MII). Indeed, compared to mothers of euploid neonates, mothers of infants with trisomy 21 due to MI non-disjunction were 8.5 times more likely to be ≥40 years old than 20-24 years old at the birth of the index case (95% CI = 5.6-12.9). Where non-disjunction occurred in MII, mothers were 15.1 times more likely to be ≥40 years (95% CI = 8.4-27.3) (Allen, Freeman et al., 2009 ). Women's age has a major impact on the rate of chronic maternal diseases and pregnancy outcome. Indeed, the rate of diabetes increases with maternal age. The 2010 National Vital Statistics Reports reported that in 2007 the rate of diabetes among USA mothers under the age of 20 was 14.0 per 1,000, and it increases almost 7 times higher to 100.5 per 1,000 in women over the age of 40 (Table 1) . Similar trends were reported regarding the rate of chronic hypertension. The prevalence of this disease increases from 3.9 per 1000 in women younger than 20 years old to 32.2 per 1000 in women older than 40. In contrast to the linear association between diabetes, as well as chronic hypertension and maternal age, the incidence of gestational hypertension as a function of maternal age has a U shape curve with a prevalence of 41.8 per 1000 among patients under 20 years and 50.1 per 1000 for women over 40, and the lowest incidence is between 20-35 years old. Similarly to the National Vital Statistics Reports, a different population based cohort involving 1,160,000 women delivered during a 2-year period found increased rate of preeclampsia and gestational diabetes among women aged 40 years or older in comparison to those aged 20-29 (Gilbert, Nesbitt et al., 1999) . Yogev et al (Yogev, Melamed et al., 2010) stratified the rate of pregnancy complication according to maternal age with a special attention to women aged ≥45 years (n = 177) with an additional subgroup analysis of women aged 45-49 years with those women aged ≥50 years. Similar to previous studies the authors reported that the rates of gestational diabetes mellitus and hypertensive complications of pregnancy were increased among women aged 45 years and older. Maternal age also influences perinatal outcome, small-for-gestational age births (SGA) are common and can have serious immediate consequences for the infant (Das and Sysyn, 2004; Salem, Levy et al., 2011) . They have also been associated with the development of a range of chronic diseases in subsequent adult life (Nepomnyaschy and Reichman, 2006; Barker, 2004) . There is an association between maternal age and the delivery of an SGA neonate. In the FASTER trial, patients aged 35-39 years were at increased risk to a deliver low birthweight neonate (adjusted OR 1.6) (Cleary-Goldman, . In addition, Salem-Yaniv et al, in a retrospective population based study found a significant increase in low birth weight among older women (35) (36) (37) (38) (39) (40) 144, 018) . This study has found that the odds of low birth weight were reduced with increasing maternal age and with a history of a previous pregnancy (either spontaneous or following IVF) (Nelson and Lawlor, 2011) . Similarly to these findings, Erez et al reported that among patients with twin gestation who conceived through ART the rate of preeclampsia was higher in women younger than 35 years old than in older parturient (Erez, Vardi et al., 2006) . These reports suggest that among patients who suffers from infertility the background maternal illness may be more severe and with clinical implication that is additive to the effect of maternal age. Advanced maternal age also influences the rate of preterm delivery. 
Pregnancy outcome in patients conceived through assisted reproduction
IVF pregnancies are associated with an increased risk for obstetrics complication including gestational diabetes, preeclampsia, placenta previa and neonatal intensive care admission 
The association between preterm birth and assisted reproduction
Preterm delivery is the leading cause for perinatal morbidity and mortality worldwide (Goldenberg, Culhane et al., 2008 ART are associated with increased rate of pregnancy complication. Several questions are being raised in regard with this topic:1) what are the causes or mechanisms leading for such complications? Is it the treatment or the underlying maternal condition that leads to infertility? 2) Are these complications due to multiple gestation or they affect also singleton gestations? 3) Is there an association with between the ART protocol and adverse pregnancy outcome?
The association between ART and multiple gestations
There is a direct relationship between the rise in the use of assisted reproduction and the increasing rate of multiple gestations. This trend is mostly due to the transfer of multiple embryos. In spite of the new regulation regarding the maximal embryos transferred during IVF cycle. In 2008, among the ART cycles that used fresh non-donor eggs or frozen-thawed embryos and progressed to the embryo transfer stage, approximately 38% involved the transfer of three or more embryos, about 13% of cycles involved the transfer of four or more embryos, and approximately 4% of cycles involved the transfer of five or more embryos. In addition, ART conceived pregnancies have a higher rate of zygotic splitting in cycles were a single embryo was transferred resulting in increased rate of monochorionic twins than spontaneously conceived pregnancies (Blickstein, Jones et al., 2003; Blickstein, Verhoeven et al., 1999) . Among the 38,631 pregnancies that resulted from ART cycles using fresh nondonor eggs or embryos, approximately 61% were singleton, 29% were twins, and about 4% were triplets or more. Approximately 32% of the pregnancies ending in live births produced more than one infant (30% twins and approximately 2% triplets or more). This compares with a multiple-infant birth rate of slightly more than 3% in the general U.S. population Figure 5 . The proportions of multiple birth in Europe is lower than in the USA, and is declining in the recent years. Indeed, the proportion of singleton, twin and triplet deliveries after IVF and ICSI combined was 79. . Collectively these studies suggest that in comparison to spontaneously conceived twin gestations, twin pregnancies that result from ART are at increased for preterm birth especially between 32-36 weeks of gestation.
Are singleton ART pregnancies at increased risk for preterm birth?
One of the major questions regarding the association between ART and preterm birth was whether this effect is mainly due to the increase in the rate of multiple pregnancies or is it relevant also for singleton gestations (Jackson, The mechanisms in which assisted reproduction technologies increases the risk for preterm birth are still under investigation. Aside the contribution of ART to the increase number of multiple gestations (especially twins) that increases the risk for preterm delivery; the mechanisms leading to preterm delivery in singleton gestation conceived by ART have not been thoroughly investigated yet. Preliminary evidence suggests that underlying maternal conditions that may lead to infertility including insulin resistance and inflammation may contribute to this observation.
Preterm parturition as a syndrome
The implicit paradigm that has governed much of the study of preterm parturition is that term and preterm labor are fundamentally the same process except for the gestational age at which they occur (Romero, Espinoza et al., 2004a; Romero, Espinoza et al., 2006b) and share a 'common pathway'. The common pathway of human parturition is defined as the anatomical, physiological, biochemical, endocrinological, immunological, and clinical events that occur in the mother and/or fetus in both term and preterm labor. The fundamental difference between term and preterm parturition is that the former results from physiological activation of the common pathway, while preterm labor arises from pathological processes that extemporaneously activate one or more of the components of the common pathway of parturition. In conclusion, treatment of bacterial vaginosis before 20 weeks of gestation in patients with a history of previous preterm birth, may reduce the risk for preterm PROM and low birthweight.
Utero-placenta ischemia
Abnormal placentation and vascular lesions in the fetal and maternal sides of the placenta are the second most prevalent lesions observed in patients who deliver preterm (Arias, Rodriquez et al., 1993) . Several possible mechanisms can lead to such findings including vaginal and decidual bleeding, spontaneous or iatrogenic death of intrauterine sibling, and uterine vascular changes such as atherosclerosis that are more prevalent in older parturient. (Naeye, 1983) reported that sclerotic lesions in the myometrial arteries are a possible cause of underperfusion because the proportion of arteries with these lesions increased from 11% at age 17 to 19 years to 83% after the age of 36. This finding is in accord with the report that uterine artery PI during pregnancy increases with maternal age (Pirhonen, Bergersen et al., 2005) . These observations are supported also by the clinical findings including an increased rate of SGA neonates among patients with preterm labor and intact membranes as well as those with preterm PROM, and the higher prevalence of low birthweight in ART pregnancies. Decidual bleeding is thought to play a role in the pathogenesis of preterm labor and preterm PROM leading to preterm birth. Indeed, hemosiderin deposition, that are regarded as a marker for bleeding are found in the decidua and retro-chorionic hematoma formation is present in 37.5% of patients who deliver preterm after PROM between 22 and 32 weeks of gestation, and 36% of patients with preterm delivery and intact membranes (Salafia, LopezZeno et al., 1995) . In contrast these lesions are found only in 0.8% of placentas of those who deliver at term. , 2007) . Evidence in support of the increase activation of the coagulation cascade among patients with preterm labor and intact membranes as well as women with preterm PROM include: 1) women with spontaneous preterm labor without intra-amniotic infection or inflammation and women with vaginal bleeding who delivered preterm, have a lower median maternal plasma protein Z (a co factor of protein Z dependent protease inhibitor that inhibits the activity of factor X) than that of normal pregnant women ; 2) regardless to the presence of intra-amniotic infection/inflammation, women with preterm labor and intact membranes have a higher median tissue factor activity and a lower median tissue factor pathway inhibitor than those with a normal pregnancy 3) patients with preterm PROM have a higher median maternal plasma tissue factor concentration and a lower median TFPI concentrations than normal pregnant women Moreover, increased thrombin generation was detected not only in the maternal circulation but also in the amniotic fluid (Erez,Romero,et al.,2009 ). Women with preterm labor who delivered preterm had a higher median thrombin anti-thrombin III concentration than those who delivered at term (Erez, Romer et al., 2009 ). This was particularly evident among those without intra-amniotic infection/inflammation, in which elevated amniotic fluid of thrombin anti-thrombin complex concentrations were associated with a shorter amniocentesis to delivery interval and a lower gestational age at delivery than those with normal or low concentrations of this complex (Erez,Romero,et al.,2009) . A vanishing twin can be an additional possible source for increase intrauterine thrombin generation that may lead to preterm birth. Indeed, vanishing twins among women who conceived by IVF/ICSI was associated with a higher rate of preterm birth <37 and <32 weeks of gestation, especially in the vanishing of the twin occur in later stages of gestation (Pinborg, Lidegaard et al., 2005) . A possible explanation for this observation is the report that intrauterine fetal demise is associated with an increased intra-amniotic thrombin generation ). This may be the case also in patients with a vanishing twin, meaning, the increased thrombin generation associated with the dissolving of the dead twin increases the risk for preterm delivery of the surviving fetus. Thrombin can activate preterm parturition through several mechanisms: 1) it has a uterotonic activity, indeed, the administration of a whole blood into a non-pregnant uterus generated uterine contractions that were not evident when saline or heparinzed blood were introduced into the uterine cavity 
Uterine over-distention
Women with a multiple pregnancy are at increased risk for spontaneous preterm labor and preterm birth. Intra-amniotic pressure remains relatively constant throughout gestation despite the growth of the fetus and placenta. This has been attributed to progressive myometrial relaxation due to the effects of progesterone and endogenous myometrial relaxants such as nitric oxide ( . Stretch may not only induce increased myometrial contractility but may also modify the contractile response through 'mechanoelectrical feedback' similar to the one reported in the heart. The chorioamniotic membranes are distended by 40% at 25-29 weeks of gestation, 60% at 30-34 weeks of gestation, and 70% at term (Millar, Stollberg et al., 2000) . Stretching of the membranes in vitro induces histological changes characterized by elongation of the amnion cells and increased production of collagenase activity and IL-8 (Maradny, Kanayama et al., 1996; Maehara, , while stretching of amnion cells in culture results in increased production of prostaglandin E2 (Kanayama and Fukamizu, 1989) . Recent studies using an in vitro cell culture model for fetal membrane distension revealed upregulation of IL-8 and pre-B-cell colony-enhancing factor (Nemeth, Tashima et al., 2000) . When fetal membrane explants were distended in an in vitro distension device to mimic the situation in vivo, and the gene expressions of distended explants were compared with that of nondistended explants, three genes, namely IL enhancer binding factor 2, huntingtininteracting protein 2, and interferon-stimulated gene encoding a 54 kDa protein, were found to be upregulated (Nemeth, Millar et al., 2000) . Collectively, these observations suggest that mechanical forces associated with uterine overdistension may result in activation of mechanisms leading to membrane rupture.
Insulin resistance
The association between infertility and maternal insulin resistance is well documented and polycystic ovary disease is its classical feature (Lobo, 1995; Barbieri, 1992 
Endocrine effect of ART
The controlled ovarian hyperstimulation during ART cycles has endocrine implication that may contribute to the increasing rate of preterm birth in these patients. Human Chorionic Gonadotropin (hCG) induces the secretion of relaxin by the corpus luteum (Kristiansson, Svardsudd et al., 1996; Weiss, Goldsmith et al., 1993) . Due to the ovarian hyperstimulation during ART cycle the maternal luteal mass is more prominent than that observed during spontaneously conceived pregnancies resulting in the significant increase in relaxin secretion in response to hCG, and indeed, pregnancies following ART were associated with hyper relaxinemia (Kristiansson, Svardsudd et al., 1996; Weiss, Goldsmith et al., 1993) . Higher maternal relaxin concentrations were found to be significantly associated with preterm birth ( 
Prevention of preterm birth
The prevention of preterm birth is one of the major objectives of modern obstetrics. In the US there is an initiative to reduce the rate of preterm birth to 6.1% by 2010, and the March of Dimes has made this topic its main field of interest. In spite of all efforts, at present there is no specific treatment for spontaneous preterm birth and this is attributed to the syndromic nature of preterm delivery that cannot be resolved by a single medication or intervention.
Currently there is wide agreement regarding the beneficial effect of two treatments: (1) the administration of corticosteroids for patients at risk for preterm birth to reduced acute neonatal morbidity; and (2) prophylactic antibiotic treatment for patients with preterm PROM that has occurred from 24 to 32 weeks of gestation (Mercer, Miodovnik et al., 1997; Kenyon, Taylor et al., 2001) but not for preterm labor with intact membranes . This treatment has been proven to prolong pregnancy and reduce the rate of acute neonatal morbidity in patients with preterm PROM . However, the results of the follow up of children after 7 years were as follows: (1) In children who were born after preterm PROM, neither antibiotic regime was associated with a significant effect on the overall level of behavioral, medical status and academics achievements (Kenyon, Pike et al., 2008) . (2) In contrast, prophylactic antibiotic treatment of patients with preterm labor had a negative effect on the children's outcome at the age of 7. Treatment with erythromycin was associated with increased functional impairment of children of mother with preterm labor and intact membranes (Kenyon, Pike et al., 2008) . The more worrisome outcome was the higher rate of cerebral palsy among children whose mothers were treated with erythromycin (OR 1.93, 95% CI 1.21-3.09) as well as in those treated with co-amoxicalve (OR 1.69, 95% CI 1.07-2.67) (Kenyon, Pike et al., 2008) . Thus, prophylactic antibiotic treatment should not be administrated to patients and preterm labor with intact membranes. Yet, these treatments are targeted to reduce the rate of complications rather than to prevent the "disease". In the recent years, attempts to prevent spontaneous preterm birth are mainly by two approaches: (1) the administration of progesterone to patients with a history of preterm birth or with a short sonographic cervix; and (2) placement of a cerclage for cervical os insufficiency.
Progesterone for the prevention of preterm birth
Progestogens administration for the prevention of recurrent abortion or preterm birth has been a subject of investigation (Papiernik-Berkhauer, 1970; LEVINE, 1964 , 2007) . However, these conclusions must be considered tentative because they derive from a secondary analysis which is intended to be hypothesis-generating. In contrast to the results in singleton gestations, the administration of progesterone for the prevention of preterm birth in twin gestation had no beneficial effect. Hartikainen-Sorri et al (Hartikainen-Sorri, Kauppila et al., 1980) more than twenty-five years ago, and recently Rouse et al (Rouse, Caritis et al., 2007) reported the results of a multicenter, placebocontrolled, double-blind, randomized clinical trials of 17-OHPC for prevention of preterm birth in twin pregnancies. Both studies concluded that there was no beneficial effect of 17-OHPC administration for the prevention of preterm birth in twin gestation.
The role of cervical cerclage in the prevention of preterm birth
Keeping with the view that cervical insufficiency is a mechanical disorder of the cervix, placement of a cervical stitch (cerclage) has been proposed as a treatment for this disorder. The study included patients with a short cervix (cervical length between 10-20 mm) who were randomized at 19-24 weeks to the administration of daily vaginal progesterone gel vs. placebo, regardless to their obstetrical history. 32,091 were screened, of them 733 had a short cervix, and 465 were randomized. Women at the progesterone group had a significant reduction in the rate of preterm birth before 33 weeks of gestation and a significant lower rate of neonatal complications in comparison to those in the placebo group . Thus, cervical length is an effective risk assessment tool for the identification of patients at risk for preterm birth and vaginal progesterone gel can prevent preterm delivery in a significant portion of patients with a short cervix.
Summary
Assisted reproduction aids a substantial proportion of women to conceive and deliver, however, these pregnancies are at increased risk for preterm birth. Some of the mechanisms leading to preterm parturition in these patients are inherited from the nature of conception like multiple gestations along with their complications. In addition, especially among singleton gestations, ART are an independent risk factor for preterm delivery and this may result from the underlying mechanisms leading to maternal infertility like infection/inflammation of the genital tract as well as other mechanisms. Thus, women who conceived following ART cycles should be followed and treated as a patient at risk for preterm birth.
